Suchergebnisse - "Haslwanter, Denise"

PubPharm (3)

1

Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine : a randomised, placebo-controlled, first-in-human trial

enthalten in: Lancet (London, England) | 2023

von Tschismarov, R. | Van Damme, P. | Germain, C. | +13

CommentIn: Lancet. 2023 Apr 15;401(10384):1242-1243. - PMID 36934735

2

Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies

enthalten in: Cell host & microbe | 2022

von Haslwanter, D. | Lasso, G. | Wec, A. | +17

CommentIn: Cell Host Microbe. 2022 Feb 9;30(2):151-153. - PMID 35143767

3

Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2020

von Wec, A. | Haslwanter, D. | Abdiche, Y. | +15

1
[1]